APA (7th ed.) Citation

Purser, M., Mladsi, D., & Kaye, J. (2016). PCN130 - Cost-Efffectivenes of Sonidegib Versus Vismodegib for The Treatment of Patients with Locally Advanced Basal Cell Carcinoma Not Amenable to Surgery or Radiotherapy. Value in Health, 19(7), A731. https://doi.org/10.1016/j.jval.2016.09.2204

Chicago Style (17th ed.) Citation

Purser, M., D. Mladsi, and JA Kaye. "PCN130 - Cost-Efffectivenes of Sonidegib Versus Vismodegib for The Treatment of Patients with Locally Advanced Basal Cell Carcinoma Not Amenable to Surgery or Radiotherapy." Value in Health 19, no. 7 (2016): A731. https://doi.org/10.1016/j.jval.2016.09.2204.

MLA (9th ed.) Citation

Purser, M., et al. "PCN130 - Cost-Efffectivenes of Sonidegib Versus Vismodegib for The Treatment of Patients with Locally Advanced Basal Cell Carcinoma Not Amenable to Surgery or Radiotherapy." Value in Health, vol. 19, no. 7, 2016, p. A731, https://doi.org/10.1016/j.jval.2016.09.2204.